BIOBANK LPCE-NICE CHEST

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "BIOBANK LPCE-NICE CHEST"

Transcription

1 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : N LH N LB ID : RO A onsent : YES Age : 54 Diagnosis and staging : chronic pleuresia 5x1000µL

2 BIOBANK LE-NIE HEST athologist : M. ILIE 12/02/2013 Time for frozen procedure : 28 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 54 Sex : F ID : MO L Diagnosis and staging : squamous cell carcinoma grade 3 pt4n0 stage IIB Diagnosis of frozen specimens : squamous cell carcinoma Size : 7.5 cm Location : left upper lobe Weights : D1 : 107 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 117 mg, R2 : 111 mg, R3 : 91 mg, R4 : 70 mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : left upper lobe Histology : mild alveolitis 2D- Specimens for diagnosis : Weights : D1 : 200 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 180 mg, R2 : 180 mg, R3 : 90 mg, R4 : 129 mg 4- ontrols of quality x1000µL erilesion

3 BIOBANK LE-NIE HEST athologist :. BUTORI 12/03/2013 LE / HU Unit atient : LH N LB ID : DE JE onsent : YES Age : 64 Diagnosis and staging : ISET 1257 Old tuberculosis and squamous cell carcinoma 3x1000µL

4 BIOBANK LE-NIE HEST athologist :. BUTORI 12/03/2013 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH N LB onsent : NO Age : 48 ID : BL DI Diagnosis and staging : adipous tissu Diagnosis of frozen specimens : adipous tissu Size : 3 x 2 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 196 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 312 mg, R2 : 352 mg 4- ontrols of quality Not available erilesion

5 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/04/2013 Time for frozen procedure : 16 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 63 ID : TO NO Diagnosis and staging : biphasic mesothelioma lung metastasis (vaginal testis) Diagnosis of frozen specimens : biphasic mesothelioma Size : 2 cm Location : lingula Weights : D1 : 18 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 16 mg, R2 : 25 mg, R3 : 13 mg, R4 : 9 mg ercent of tumor cells : 90 % 2- erilesional tissue specimens Location : lingula Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 34 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 18 mg, R2 : 21 mg, R3 : 12 mg, R4 : 23 mg 4- ontrols of quality 4x1000µl erilesion

6 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/04/2013 Time for frozen procedure : 14 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 74 Sex : F ID : I LI Diagnosis and staging : siewert type 1 adenocarcinoma of the oesophagus post chemotherapy pt3n1 Diagnosis of frozen specimens : grade 2 adenocarcinoma Size : 3 x 2.5 cm Location : oesogastric jonction Weights : D1 : 38 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 50 mg, R2 : 45 mg, R3 : 56 mg, R4 : 25 mg ercent of tumor cells : 60 % 2- erilesional tissue specimens Location : lower oesophagus Histology : normal mucosis 2D- Specimens for diagnosis : Weights : D1 : 29 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 42 mg, R2 : 40 mg, R3 : 35 mg, R4 : 40 mg 4- ontrols of quality erilesion

7 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 06/12/2013 Time for frozen procedure : 8 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 60 Sex : F ID : AM MA Diagnosis and staging : metastatic (lymph node) lung neuroendocrine small cell carcinoma (ptxn2mx) Diagnosis of frozen specimens : neuroendocrine small cell carcinoma Size : 0.5 cm Location : site 7 2- erilesional tissue specimens None Weights : D1 : 47 mg 1R- Specimens for research : Nb : 1 Weights : R1 : 31 mg ercent of tumor cells : 20 % 4- ontrols of quality Not available erilesion

8 BIOBANK LE-NIE HEST LE / HU Unit athologist : E. LONG-MIRA 12/06/2013 lamp : 15 mn ; Frozen procedure : 48 mn ; T : 63 mn atient : N LH N LB onsent : NO Age : 61 ID : O MA Diagnosis and staging : mild differentiated squamous cell carcinoma (pt3n1mx) Diagnosis of frozen specimens : inflammatory fibrosis, no tumor cell Size : 15 x 6 cm Location : left lower lobe Weights : D1 : 152 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 132 mg, R2 : 182 mg, R3 : 129 mg, R4 : 128 mg ercent of tumor cells : 0 % 2- erilesional tissue specimens Location : left lower lobe Histology : alveolitis 2D- Specimens for diagnosis : Weights : D1 : 58 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 220 mg, R2 : 175 mg, R3 : 108 mg, R4 : 73 mg 4- ontrols of quality 2x1000µL erilesion

9 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 67 Sex : F ID : MA DA Diagnosis and staging : type B3 thymoma largely invasive with pleuro diaphragmatic implants Diagnosis of frozen specimens : type B3 thymoma Size : 4.5 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 124 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 118 mg, R2 : 144 mg, R3 : 88 mg, R4 : 120 mg ercent of tumor cells : 70 % 4- ontrols of quality Not available 3x1000µL erilesion

10 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 Time for frozen procedure : 8 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 65 ID : ES JA Diagnosis and staging : lung adenocarcinoma lymph node metastasis Diagnosis of frozen specimens : solid adenocarcinoma with mucinous secretion Size : 0.6 cm Location : right site 2 2- erilesional tissue specimens None Weights : D1 : 21.5 mg ercent of tumor cells : 60 % 4- ontrols of quality For diagnosis bank : YES L1 (tube D1): : 0,20445 µg/µl ; Tot qty: 34.9 µg DO 260/ ; R pyro EGFR : OK Biobank - LM Not available erilesion

11 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : LH N LB ID : MA DO onsent : YES Age : 57 Diagnosis and staging : ISET 1266 ost traumatic necrosis, no tumor 1x1000µL

12 BIOBANK LE-NIE HEST LE / HU Unit athologist : V. HOFMAN 12/10/2013 lamp : 10 mn ; Frozen procedure : 30 mn ; T : 40 mn atient : N LH N LB onsent : NO Age : 66 Sex : F ID : DE H Diagnosis and staging : grade 2 adenocarcinoma acinous predominant with papillary component pt1bnx and second adenocarcinoma with minimal invasion of the left lower lobe pt1a Diagnosis of frozen specimens : adenocarcinoma acinous predominant Size : 2.5 x 2 cm Location : left upper lobe Weights : D1 : 85 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 92 mg, R2 : 123 mg, R3 : 49 mg ercent of tumor cells : 40 % 2- erilesional tissue specimens Location : left upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 75 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 60 mg, R2 : 77 mg, R3 : 79 mg, R4 : 84 mg 4- ontrols of quality For diagnosis bank : YES 2x1000µL erilesion

13 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/10/2013 Time for frozen procedure : 60 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 58 Sex : F ID : DA TH Diagnosis and staging : nodular tuberculosis probably Diagnosis of frozen specimens : nodular tuberculosis Size : 2 cm Location : left lower lobe Weights : D1 : 25 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 26 mg, R2 : 23 mg, R3 : 15 mg, R4 : 18 mg 2- erilesional tissue specimens Location : left lower lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 12 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 18 mg, R2 : 15 mg, R3 : 22 mg, R4 : 24 mg 4- ontrols of quality Infection : YES (tuberculosis) erilesion

14 BIOBANK LE-NIE HEST athologist : M. ILIE 12/11/2013 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 ID : TE H Diagnosis and staging : undifferentiated malignant tumor with spindle cells (p63+, Vim+, WT1+). Diagnosis of frozen specimens : undifferentiated malignant tumor (mesopath : malignant inclassed tumor, sarcomatoid carcinoma? Size : 1 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 35 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 23 mg, R2 : 49 mg, R3 : 44 mg ercent of tumor cells : 85 % 4- ontrols of quality Not available 2x1000µL erilesion

15 BIOBANK LE-NIE HEST LE / HU Unit athologist : M. ILIE 12/11/2013 lamp : 8 mn ; Frozen procedure : 27 mn ; T : 35 mn atient : N LH N LB onsent : YES Age : 78 Sex : F ID : BR AL Diagnosis and staging : mucinous adenocarcinoma with solid, «signet-ring», micropapillary component pt2an0mx (IIB) Diagnosis of frozen specimens : mucinous adenocarcinoma Size : 3 cm Location : right lower lobe Weights : D1 : 78 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 110 mg, R2 : 82 mg, R3 : 45 mg, R4 : 90 mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : right lower lobe Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 250 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 180 mg, R2 : 167 mg, R3 : 243 mg, R4 : 144 mg 4- ontrols of quality For diagnosis bank : YES 2x1000µL erilesion

16 BIOBANK LE-NIE HEST LE / HU Unit athologist : M. ILIE 12/11/2013 lamp : 15 mn ; Frozen procedure : 60 mn ; T : 75 mn atient : N LH N LB onsent : YES Age : 70 Sex : F ID : MI MA Diagnosis and staging : atypical carcinoid pt1an1 Diagnosis of frozen specimens : atypical carcinoid Size : 1.7 cm Location : left upper lobe Weights : D1 : 121 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 110 mg, R2 : 160 mg 2- erilesional tissue specimens Location : left upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 139 mg 2R- Specimens for research : Nb : 2 Weights : R1 : 180 mg, R2 : 160 mg ercent of tumor cells : 70 % 4- ontrols of quality 3 x1000µl erilesion

17 BIOBANK LE-NIE HEST athologist : M. ILIE 12/11/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 79 ID : BO JO Diagnosis and staging : mucinous acinous adenocarcinoma grade 3 pt3n0mx (IIB) Diagnosis of frozen specimens : mucinous acinous adenocarcinoma Size : 5.5 x 4.5 x 4 cm Location : right upper lobe Weights : D1 : 68 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 44 mg, R2 : 83 mg, R3 : 105 mg, R4 : 34 mg ercent of tumor cells : 80 % 2- erilesional tissue specimens Location : right upper lobe Histology : moderate emphysema 2D- Specimens for diagnosis : Weights : D1 : 150 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 70 mg, R2 : 83 mg, R3 : 113 mg, R4 : 75 mg 4- ontrols of quality L(1) (tube D1): : 0,16374 µg/µl ; Tot qty: 27,2 µg DO 260/ ; R pyro EGFR : OK L(2) (tube D1): : 0,09577 µg/µl ; Tot qty: 18.8 µg DO 260/ ; R pyro KRAS : OK Biobank - LM erilesion

18 BIOBANK LE-NIE HEST athologist : S. LASSALLE 12/12/2013 LE / HU Unit atient : N LH N LB onsent : NO Age : 44 ID : SI H Diagnosis and staging : leiomyosarcoma lung metastasis Sex : F For diagnosis bank : YES 2 x 1000 µl 1 x 500 µl

19 BIOBANK LE-NIE HEST athologist : S. LASSALLE 12/12/2013 LE / HU Unit atient : N LH N LB onsent : YES Age : 75 ID : NI JE Diagnosis and staging : acinar predominant adenocarcinoma, pt2an2 Infection : unknown For diagnosis bank : YES 3x1000µl

20 BIOBANK LE-NIE HEST athologist : M. ILIE 12/13/2013 LE / HU Unit atient : N LH N LB onsent : NO Age : 34 ID : DE LA Diagnosis and staging : site 7 lymph node with acidophil ischemic necrosis without granuloma (no etiology) Sex : F 2x1000µL

21 BIOBANK LE-NIE HEST athologist : M. ILIE 12/13/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 57 ID : BO HO Diagnosis and staging : lung adenocarcinoma pleural metastasis Diagnosis of frozen specimens : lung adenocarcinoma pleural metastasis Size : 1.5 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 52 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 30 mg, R2 : 31 mg ercent of tumor cells : 20 % 4- ontrols of quality For diagnosis bank : YES Not available 1x1000µL erilesion

22 BIOBANK LE-NIE HEST athologiste :. BUTORI 16/12/2013 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 66 Sex : F ID : JU MA Diagnosis and staging : (probably breast) sarcomatoid carcinoma parietal metastasis Diagnosis of frozen specimens : sarcomatoid carcinoma Size : 3 cm Location : chest parietal 2- erilesional tissue specimens None Weights : D1 : 172 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 143 mg, R2 : 139 mg, R3 : 191 mg, R4 : 115 mg ercent of tumor cells : 90 % 4- ontrols of quality Not available 4x1000µL erilesion

23 BIOBANK LE-NIE HEST athologist :. BUTORI 12/16/2013 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 63 Sex : F ID : DA MI Diagnosis and staging : mediastinal schwannoma Diagnosis of frozen specimens : schwannoma Size : 2.8 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 225 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 195 mg, R2 : 172 mg, R3 : 127 mg, R4 : 139 mg ercent of tumor cells : 80 % 4- ontrols of quality For diagnosis bank : YES Not available 1x1000µL erilesion

24 BIOBANK LE-NIE HEST athologist :. BUTORI 12/16/2013 Time for frozen procedure : 6 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 75 ID : LA I Diagnosis and staging : encapsulated type A thymoma Diagnosis of frozen specimens : type A thymoma Size : 2 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 83 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 82 mg, R2 : 23 mg ercent of tumor cells : 80 % 4- ontrols of quality Not available erilesion

25 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/17/2013 Time for frozen procedure : 35 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 58 Sex : F ID : NO AN Diagnosis and staging : large cell carcinoma pt1an0 Diagnosis of frozen specimens : large cell carcinoma Size : 2 cm Location : Nelson Weights : D1 : 24 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 36 mg, R2 : 38 mg, R3 : 32 mg, R4 : 38 mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : Nelson Histology : respiratory bronchiolitis 2D- Specimens for diagnosis : Weights : D1 : 74 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 40 mg, R2 : 40 mg, R3 : 71 mg, R4 : 67 mg 4- ontrols of quality 3x 1000µL erilesion

26 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/17/2013 Time for frozen procedure : 25 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 ID : RE MA Diagnosis and staging : malignant solitary fibrous pleural tumor Diagnosis of frozen specimens : malignant solitary fibrous pleural tumor Size : 25 cm Location : right pleura 2- erilesional tissue specimens None Weights : D1 : 94 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 122 mg, R2 : 144 mg, R3 : 170 mg, R4 : 120 mg ercent of tumor cells : 30 % 4- ontrols of quality For diagnosis bank : YES Not available 1 x1000µl erilesion

27 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/18/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 72 ID : LE JE Diagnosis and staging : metastatic melanoma Diagnosis of frozen specimens : metastatic melanoma Size : 2 x 1.7 cm Location : lingula Weights : D1 : 61 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 58 mg, R2 : 38 mg, R3 : 35 mg, R4 : 37 mg ercent of tumor cells : 90 % 2- erilesional tissue specimens Location : lingula Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 51 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 51 mg, R2 : 44 mg, R3 : 28 mg, R4 : 35 mg 4- ontrols of quality L1 (tube D1): : 0,24348 µg/µl ; Tot qty: 43,2 µg DO 260/280: 2,02 ; R pyro EGFR : OK Biobank - LM 3x1000µL erilesion

28 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/18/2013 Time for frozen procedure : 16 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 Sex : F ID : I GE Diagnosis and staging : acinous and papillary invasive adenocarcinoma (pt1an0mx) Diagnosis of frozen specimens : acinous and papillary adenocarcinoma Size : 1.5 x 1 cm Location : left upper lobe Weights : D1 : 27 mg 1R- Specimens for research : Nb : 1 Weights : R1 : 12 mg 2- erilesional tissue specimens Location : left upper lobe Histology : adenocarcinoma (10 %) 2D- Specimens for diagnosis : Weights : D1 : 92 mg 2R- Specimens for research : Nb : 1 Weights : R1 : 77 mg ercent of tumor cells : 50 % 4- ontrols of quality For diagnosis bank : YES erilesion

29 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/13/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 70 ID : DE HE Diagnosis and staging : large cell carcinoma lymph node metastasis Diagnosis of frozen specimens : large cell carcinoma (epidermoid ) Size : 0.3 to 0.7 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 71 mg 1R- Specimens for research : Nb : 1 Weights : R1 : 70 mg ercent of tumor cells : 60 % 4- ontrols of quality Not available erilesion

30 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/18/2013 Time for frozen procedure : 30 mn LE / HU Unit atient : N LH N LB onsent : Refusal of consent ID : AD E Age : 45 Sex : F Diagnosis and staging : metastatic lung adenocarcinoma (lymph node) ptxn3mx Diagnosis of frozen specimens : metastatic Lung adenocracinoma Size : 1.6 cm Location : sus clavicular lymph node Weights : D1 : 105 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 39 mg, R2 : 52 mg, R3 : 51 mg 2- erilesional tissue specimens None ercent of tumor cells : 20 % 4- ontrols of quality Infection : YES (HIV) For diagnosis bank : YES L1 (tube D1): : 0,19391 µg/µl ; Tot qty: 32.8 µg DO 260/280: 1,97 ; R pyro EGFR : OK Not available Biobank - LM erilesion

31 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/19/2013 LE / HU Unit atient : N LH N LB onsent : YES Age : 65 ID : ME GE Diagnosis and staging : lung adenocarcinoma, acinar predominant (grade 3), pt1an1 For diagnosis bank : YES 3x1000µL

32 BIOBANK LE-NIE HEST athologist : M. ILIE 12/18/2013 Time for frozen procedure : 5 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 61 ID : BE JE Diagnosis and staging : small cell neuroendocrin carcinoma lymph node metastasis Diagnosis of frozen specimens : small cell neuroendocrin carcinoma Size : 1 cm Location : lymph node site 4 2- erilesional tissue specimens None Weights : D1 : 105 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 74 mg, R2 : 90 mg, R3 : 84 mg ercent of tumor cells : 90 % 4- ontrols of quality Not available 2x1000µL erilesion

33 BIOBANK LE-NIE HEST LE / HU Unit athologist : S. LASSALLE 12/23/2013 lamp : 15 mn ; Frozen procedure : 140 mn ; T : 155 mn atient : N LH N LB onsent : YES Age : 50 ID : BA H Diagnosis and staging : squamous cell carcinoma (grade 2), ypt2an1 Diagnosis of frozen specimens : squamous cell carcinoma Size : 5 cm Location : right lobe Weights : D1 : 46 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 67 mg, R2 : 66 mg, R3 : 60 mg 2- erilesional tissue specimens Location : right lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 124 mg 2R- Specimens for research : Nb : 3 Weights : R1 : 103 mg, R2 : 104 mg, R3 : 72 mg ercent of tumor cells : 60 % 4- ontrols of quality Infection : Unknown 4 x1000µl erilesion

34 BIOBANK LE-NIE HEST athologist : S. LASSALLE 12/23/2013 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : NO Age : 57 Sex : F ID : GO IR Diagnosis and staging : lung adenocarcinoma pleural metastasis Diagnosis of frozen specimens : adenocarcinoma Location : pleura Weights : D1 : 24 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 21 mg, R2 : 28 mg 2- erilesional tissue specimens None ercent of tumor cells : 30 % 4- ontrols of quality For diagnosis bank : YES L (tube D1): : 0,13027 µg/µl ; Tot qty: 22.8 µg DO 260/ ; R pyro EGFR : OK BioBank - LM Not available erilesion

35 BIOBANK LE-NIE HEST LE / HU Unit athologist :. BUTORI 12/30/2013 lamp : 30 mn ; Frozen procedure : 15 mn ; T : 45 mn atient : N LH N LB onsent : YES Age : 33 Sex : F ID : L MA Diagnosis and staging : undifferentiated carcinoma lung metastasis Diagnosis of frozen specimens : thyroid undifferentiated carcinoma Size : 1.8 cm Location : right upper lobe Weights : D1 : 63 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 65 mg, R2 : 78 mg, R3 : 80 mg, R4 : 80 mg ercent of tumor cells : 90% (need to be verified) 2- erilesional tissue specimens Location : right upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 185 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 200 mg, R2 : 169 mg, R3 : 127 mg, R4 : 109 mg 4- ontrols of quality (tube D1): - : 0,23370µg/µl ; Tot qty: 41,6 µg -DO 260/280: 1,99 Biobank BS F.edeutour 3 x 1000 µl erilesion

36 BIOBANK LE-NIE HEST athologist :. BUTORI 12/30/2013 Time for frozen procedure : 37 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 30 Sex : F ID : VE AU Diagnosis and staging : typic carcinoid tumor pt1an0 Diagnosis of frozen specimens : typic carcinoid tumor Size : 2 cm Location : left lower lobe Weights : D1 : 30 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 40 mg, R2 : 87 mg, R3 : 26 mg, R4 : 30 mg ercent of tumor cells : 70 % 2- erilesional tissue specimens Location : distal Histology : broncho pneumonia 2D- Specimens for diagnosis : Weights : D1 : 77 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 46 mg, R2 : 89 mg, R3 : 100 mg, R4 : 53 mg 4- ontrols of quality 2 x 1000 µl erilesion

37 BIOBANK LE-NIE HEST athologist :. BUTORI 12/30/2013 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 76 ID : O SE Diagnosis and staging : malignant epithelioid mesothelioma Stage IV Diagnosis of frozen specimens : malignant epithelioid mesothelioma Size : 1 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 123 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 128 mg, R2 : 131 mg, R3 : 126 mg, R4 : 140 mg ercent of tumor cells : 80 % 4- ontrols of quality Not available 3 x 1000 µl erilesion

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/03/2011 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH 11-0004 N LB 11-0002 onsent : YES Age : 37 ID : TH ER Diagnosis and staging : Hodgkin

More information

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST HEST athologist :. BUTORI 08/01/2012 Time for frozen procedure : 45 mn LE / HU Unit atient : N LH 12-2304 N LB 12-0337 onsent : YES Age : 62 ID : MA H Diagnosis and staging : lung adenocarcinoma lymph

More information

BIOBANK LPCE-NICE. LPCE / CHU Unit. Pathologist : Dr GIORSETTI- PASCAL 02/24/2011 Time for frozen procedure : 5 mn

BIOBANK LPCE-NICE. LPCE / CHU Unit. Pathologist : Dr GIORSETTI- PASCAL 02/24/2011 Time for frozen procedure : 5 mn athologist : Dr GIORETTI- AAL 02/24/2011 Time for frozen procedure : 5 mn atient : N TZ 11-001 N LB 11-0113 ID : RA I Age : 46 ex : F Diagnosis and staging : lung adenocarcinoma lymph node metastasis TTF1-

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

YOUR LUNG CANCER PATHOLOGY REPORT

YOUR LUNG CANCER PATHOLOGY REPORT UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7

More information

Pathology of lung cancer

Pathology of lung cancer Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Lung Cancer Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Alexandria, Egypt July 1-1 3, 2008 OBJECTIVES Describe and

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

Primary -Benign - Malignant Secondary

Primary -Benign - Malignant Secondary TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low

More information

Rare Thoracic Tumours

Rare Thoracic Tumours Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC

More information

INFLAMMATORY PLEURAL EFFUSION

INFLAMMATORY PLEURAL EFFUSION PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary

More information

Neoplasms of the LUNG and PLEURA

Neoplasms of the LUNG and PLEURA Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:

More information

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnosis of Mesothelioma Pitfalls and Practical Information Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing

More information

The develpemental origin of mesothelium

The develpemental origin of mesothelium Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists

More information

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains

More information

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma

More information

Recommendations for the Reporting of Pleural Mesothelioma

Recommendations for the Reporting of Pleural Mesothelioma Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,

More information

Plueral Malignancy: Radiologic-pathologic

Plueral Malignancy: Radiologic-pathologic Plueral Malignancy: Radiologic-pathologic Correlation Ritu R. Gill, MD Pleural Malignancies: Radiologic-Pathologic Correlation Ritu R Gill MD Brigham and Women s Hospital Boston, Massachusetts Pleural

More information

Male. Female. Death rates from lung cancer in USA

Male. Female. Death rates from lung cancer in USA Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012 Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos

More information

Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron

More information

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital

More information

CHAPTER 3: LUNG CANCER OVERVIEW

CHAPTER 3: LUNG CANCER OVERVIEW CHAPTER 3: LUNG CANCER OVERVIEW INTRODUCTION Learning about lung cancer is an important part of preparing for the decisions you will be making about your treatment and aftercare. The more you know about

More information

Lung Cancer: Diagnosis, Staging and Treatment

Lung Cancer: Diagnosis, Staging and Treatment PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

Effusions of the Serous Cavities

Effusions of the Serous Cavities Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura

More information

Basic Chest X-ray Interpretation Programme 2

Basic Chest X-ray Interpretation Programme 2 Basic Chest X-ray Interpretation Programme 2 In this second chest x-ray tutorial I will now start to look at some of the more commonly encountered pathologies. I have split this up into abnormalities involving

More information

A 70-year old Man with Pleural Effusion

A 70-year old Man with Pleural Effusion Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which

More information

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short

More information

Diagnostic Challenge. Department of Pathology,

Diagnostic Challenge. Department of Pathology, Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital

More information

Pleural and Chest Wall Tumors

Pleural and Chest Wall Tumors Pleural and Chest Wall Tumors Ritu Gill, MD, MPH Dr. Ritu R. Gill Department t of Radiology Brigham and Women s Hospital Harvard Medical School CLASSIFICATION OF CHEST WALL TUMORS Primary neoplasm of chest

More information

III II II 111111111111111111111111111111111111111111 1 1111111111111 III. ge: /ears sex: Male Access

III II II 111111111111111111111111111111111111111111 1 1111111111111 III. ge: /ears sex: Male Access UUID : 10F97F63 - EE6F-448D - 98E1-8AAA21F55753 TCGA - TS-A7PB-01A-PR Redacted III II II 111111111111111111111111111111111111111111 1 1111111111111 III Date Receive III 11111111111111111 11111111111 II

More information

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12 Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society

More information

General Information About Non-Small Cell Lung Cancer

General Information About Non-Small Cell Lung Cancer General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing

More information

Lessons from a consultation practice

Lessons from a consultation practice Pitfalls in the Application of Immunohistochemistry in Diagnostic Pathology Lessons from a consultation practice Kevin O. Leslie, MD Professor and Consultant Mayo Clinic Arizona Scottsdale, Arizona Presenter

More information

Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat

Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat SAGE-Hindawi Access to Research Volume 2010, Article ID 396794, 4 pages doi:10.4061/2010/396794 Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat Alexander Th. A. Weiss, Afonso B. da Costa,

More information

About lung cancer. Contents. The lungs

About lung cancer. Contents. The lungs This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 7. The lungs Contents The lungs Types of lung cancer

More information

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.

More information

Lung Cancer: Diagnosis, Staging and Treatment

Lung Cancer: Diagnosis, Staging and Treatment PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.

More information

Ovarian tumors Ancillary methods

Ovarian tumors Ancillary methods Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

659 Heart: 1 Atrial myxoma 1. Artery: 5 Normal 5. Vein: 1 Leiomyosarcoma well-differentiated (inferior vena cava) 1

659 Heart: 1 Atrial myxoma 1. Artery: 5 Normal 5. Vein: 1 Leiomyosarcoma well-differentiated (inferior vena cava) 1 Stony Brook BioBank Specimen Collection (updated 2//6) Site Diagnosis Cardiovascular System 659 Heart: Atrial myxoma Artery: 5 Normal 5 Blood: 652 Vein: Leiomyosarcoma well-differentiated (inferior vena

More information

This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.

This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different. There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung

General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 150.3 Malignant neoplasm of upper third of esophagus C15.3 Malignant neoplasm of upper third of esophagus 150.4 Malignant neoplasm of middle

More information

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014 General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

POLICY A. INDICATIONS

POLICY A. INDICATIONS Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below

More information

Summary of treatment benefits

Summary of treatment benefits Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell

More information

The National Clinical Lung Cancer Audit (LUCADA)

The National Clinical Lung Cancer Audit (LUCADA) The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name

More information

From ICD-9-CM to ICD-10-CM. Coding for Neoplasms

From ICD-9-CM to ICD-10-CM. Coding for Neoplasms From ICD-9-CM to ICD-10-CM Presented by: Kay Kostal, M.Ed., RHIT, CCS Deborah A. Balentine, M.Ed., RHIA, CCS-P North American Association of Central Cancer Registries July 12, 2012 1 Case Studies Case

More information

Pleural and Pericardial fluids a one year analysis

Pleural and Pericardial fluids a one year analysis Pleural and Pericardial fluids a one year analysis Dr Olafsdottir Dr J Williams Department of Cytology, Llandough Hospital Contents Background Standards Aims/Questions Investigation group Results Conclusions

More information

Case based applications part III

Case based applications part III Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

More than 2,500 people are diagnosed with mesothelioma in the UK each year.

More than 2,500 people are diagnosed with mesothelioma in the UK each year. This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 5. Contents Introduction Pleural mesothelioma Peritoneal

More information

Paranasal sinus anatomy

Paranasal sinus anatomy Paranasal sinus anatomy Sphenoid Nasopharynx Respiratory mucosa Pseudostratified, goblet & ciliated cells Seromucinous glands Nasopharyngeal mucosa/carcinoma Squamous metaplasia (?) with CIS Normal respiratory

More information

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy CASE REPORT http://dx.doi.org/10.4046/trd.2015.78.3.297 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:297-301 Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy Yeon-Hee Park,

More information

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%

More information

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,

More information

R-16: Chronic nonspecific cervisit

R-16: Chronic nonspecific cervisit R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014

More information

3-F. Pathology of Mesothelioma

3-F. Pathology of Mesothelioma 3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which

More information

LUNG CANCER the new Staging System G.KIROVA TOKUDA HOSPITAL SOFIA

LUNG CANCER the new Staging System G.KIROVA TOKUDA HOSPITAL SOFIA LUNG CANCER the new Staging System G.KIROVA TOKUDA HOSPITAL SOFIA STAGING SYSTEM Provides standardized nomenclature for exchanging information Groups patients according to the biologic behavior of their

More information

Lung Opacity: Atelectasis, Consolidation, Ground Glass Opacity, and Mosaic Attenuation

Lung Opacity: Atelectasis, Consolidation, Ground Glass Opacity, and Mosaic Attenuation Lung Opacity: Atelectasis, Consolidation, Ground Glass Opacity, and Mosaic Attenuation Gautham P. Reddy, MD, MPH University of Washington Learning Objectives Identify lobar or rounded atelectasis Describe

More information

Lung Cancer Pathology Data Standards

Lung Cancer Pathology Data Standards For reference only Do Not Use For more information contact: cdsis@nhs.net Lung Cancer Pathology Data Standards June 2008 National Clinical Dataset Development Programme (NCDDP) Support Team Information

More information

Therapy of pleural effusions Modern techniques

Therapy of pleural effusions Modern techniques Therapy of pleural effusions Modern techniques Dr. Melanie Toffel Sugery of the chest Pleural effusion Ethiology In the normal pleural space there is a steady state in which there is a roughly equal rate

More information

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules Multiple Primary and Histology Site Specific Coding Rules KIDNEY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology

More information

OCCULT PRIMARY CANCER

OCCULT PRIMARY CANCER OCCULT PRIMARY CANCER พญ.ครองกมล ส หบ ณฑ หน วยมะเร งว ทยา INTRODUCTION Occult primary cancers or cancer of unknown primary (CUPS) Histologically proven metastatic malignant tumors whose primary site cannot

More information

MODERN IMMUNOHISTOCHEMISTRY

MODERN IMMUNOHISTOCHEMISTRY MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,

More information

Frozen Section Diagnosis

Frozen Section Diagnosis Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The

More information

Imaging Diagnosis and Staging of Lung Cancer By Mamdouh Mahfouz MD Radio diagnosis Cairo University

Imaging Diagnosis and Staging of Lung Cancer By Mamdouh Mahfouz MD Radio diagnosis Cairo University Imaging Diagnosis and Staging of Lung Cancer By Mamdouh Mahfouz MD Radio diagnosis Cairo University mamdouh.m5@gmail.com www.ssregypt.com Lung Cancer The most common cause of deaths worldwide Cigarette

More information

LUNG CANCER. FCDS 2011 Educational Webcast Series November 17, 2011

LUNG CANCER. FCDS 2011 Educational Webcast Series November 17, 2011 LUNG CANCER FCDS 2011 Educational Webcast Series November 17, 2011 Judy Bonner, RN, MS, CTR and Lynne Pearson, CTR, LHRM Steven Peace, CTR Updated for 2011 Requirements and CSv02.03.02 1 Presentation Outline

More information

Diagnosis and Prognosis of Thyroid Cancer

Diagnosis and Prognosis of Thyroid Cancer Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Medications Lifestyle Changes Living With Thyroid Cancer Talking

More information

Notice of Faculty Disclosure

Notice of Faculty Disclosure The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with

More information

P R E F E I T U R A M U N I C I P A L D E J A R D I M

P R E F E I T U R A M U N I C I P A L D E J A R D I M D E P A R T A M E N T O D E C O M P R A S E L I C I T A O A U T O R I Z A O P A R A R E A L I Z A O D E C E R T A M E L I C I T A T с R I O M O D A L I D A D E P R E G O P R E S E N C I A L N 034/ 2 0

More information

Thyroid and Adrenal Gland

Thyroid and Adrenal Gland Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

DIFFICULTIES IN THE PATHOLOGIC DIAGNOSIS OF LUNG CANCER Notice of Financial Disclosures (TV Colby MD) (Esp. in small biopsies) Personal Experience Thomas V. Colby, M.D. Mayo Clinic Arizona NONE This talk

More information

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses Page 1 of 5 THE PATHOLOGY OF MEDIASTINAL MASSES Dr. S. Boag 549-6666 Ext. 4190, mailto:%20boag@cliff.path.queensu.ca 1. INTRODUCTION A wide range of process, neoplastic and non-neoplastic, can produce

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Thoracic Cavity. Photo: This normal canine lung collapsed when the thorax was opened and the negative pressure was lost in the thorax.

Thoracic Cavity. Photo: This normal canine lung collapsed when the thorax was opened and the negative pressure was lost in the thorax. Thoracic Cavity There are significant anatomical differences in the mediastinum of domestic animals. For instance, bovines, like humans, have well-developed mediastinal separation between the left and

More information

October 2012 Pulmonary Case of the Month: Hemoptysis from an Uncommon Cause. Lewis J. Wesselius, MD

October 2012 Pulmonary Case of the Month: Hemoptysis from an Uncommon Cause. Lewis J. Wesselius, MD October 2012 Pulmonary Case of the Month: Hemoptysis from an Uncommon Cause Lewis J. Wesselius, MD Department of Pulmonary Medicine Mayo Clinic Arizona Scottsdale, AZ History of Present Illness A 39 year

More information

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors and malignant mesothelial neoplasms of the

More information

Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets

Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets A comparison of case ascertainment and recording of lung cancer histology and

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

Understanding Pleural Mesothelioma

Understanding Pleural Mesothelioma Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to

More information

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis

More information

34 YOM potential living liver donor. 38 YO male living liver donor candidate. Adenomatosis. FNH vs Adenoma

34 YOM potential living liver donor. 38 YO male living liver donor candidate. Adenomatosis. FNH vs Adenoma 34 YOM potential living liver donor 38 YO male living liver donor candidate Adenomatosis FNH vs Adenoma FNH Hepatobiliary agents have a role in distinguishing the two! Adenoma But beware 3 minute post

More information

Part I: NCCN Practice Guidelines Tabular Summary (DD 3/20/13) PET and PET/CT

Part I: NCCN Practice Guidelines Tabular Summary (DD 3/20/13) PET and PET/CT Part I: NCCN Practice Guidelines Tabular Summary (DD 3/20/13) PET and NCCN guidelines were reviewed on 3/20/2013 for utilization of PET and (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

Biphasic pericardial and pleural mesothelioma in a cat: a case report

Biphasic pericardial and pleural mesothelioma in a cat: a case report Veterinarni Medicina, 60, 2015 (2): 105 108 Case Report Biphasic pericardial and pleural mesothelioma in a cat: a case report S.J. Gabriel Filho 1, G.M. Magalhaes 2, V.A. Conforti 2, J. Santilli 2, S.G.

More information

A913: Liver cancer. General facts of Liver cancer

A913: Liver cancer. General facts of Liver cancer General facts of Liver cancer A913: Liver cancer There are two different types of primary liver cancer. The most common kind is called hepatoma or hepatocellular carcinoma (HCC), and arises from the main

More information